Mutations of LRRK2, including the most prominent G2019S, often lead to increased kinase activity, which is thought to contribute to the degeneration of dopaminergic neurons, a hallmark of PD, though the exact mechanisms by which mutations in LRRK2 contribute to PD are still being elucidated.5 This evidence concerns the gene LRRK2 and Parkinson disease.